Unlocking the Power of Exosomes: Revolutionizing Cancer Mutation Detection

unlocking the power of exosomes and revolutionizing cancer mutation detection

Asuragen’s tech talk at the Inside Precision Medicine event to learn more about the power of utilizing exosomes for biomarker testing and the distinctive characteristics of exosomes that make them exceptional biomarker targets.

Brian Haynes, CSO, Asuragen, a Bio-Techne brand.

View the tech talk.

Back To
Top